Food for thought⋯cellular resilience

Altex

Volumn 32, Issue 4, 2015, Pages 247-260

  Smirnova, Lena ^a   Harris, Georgina ^a   Leist, Marcel ^b   Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Cell death; Cellular defense; Cellular toxicology; Cytotoxicity; Stress pathways

Indexed keywords

ENVIRONMENTAL CHEMICAL;

APOPTOSIS; ARTICLE; CELL METABOLISM; CELLULAR PARAMETERS; CELLULAR RESILIENCE; CELLULAR STRESS RESPONSE; CYTOTOXICITY; ENVIRONMENTAL CHANGE; EPIGENETICS; HOMEOSTASIS; HORMESIS; HUMAN; NONHUMAN; ADAPTATION; ANIMAL; ANIMAL TESTING ALTERNATIVE; CELL DEATH; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; GENETICS; PHYSIOLOGICAL STRESS;

ADAPTATION, PHYSIOLOGICAL; ANIMAL TESTING ALTERNATIVES; ANIMALS; CELL DEATH; CELL PHYSIOLOGICAL PROCESSES; HUMANS; STRESS, PHYSIOLOGICAL;

EID: 84946742600     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.1509271     Document Type: Article

References (136)

1. Alastalo, H., Räikkönen, K., Pesonen, A. K. et al. (2013). Early life stress and blood pressure levels in late adulthood. J Hum Hypertens 27, 90-94. http://dx.doi.org/10.1038/jhh.2012.6
2. Andersen, M. E., McMullen, P. D. and Krewski, D. (2015). Developing tools for defining and establishing pathways of toxicity. Arch Toxicol 89, 809-812. http://doi.org/10.1007/s00204-015-1512-y
3. Araujo, R. P. and Liotta, L. A. (2006). A control theoretic paradigm for cell signaling networks: A simple complexity for a sensitive robustness. Curr Opin Chem Biol 10, 81-87. http://doi.org/10.1016/j.cbpa.2006.01.002
4. Araujo, R. P., Liotta, L. A. and Petricoin, E. F. (2007). Proteins, drug targets and the mechanisms they control: The simple truth about complex networks. Nat Rev Drug Discov 6, 871-880. http://doi.org/10.1038/nrd2381
5. Balmer, N. V. and Leist, M. (2014a). Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development. Basic Clin Pharmacol Toxicol 115, 59-68. http://dx.doi.org/10.1111/bcpt.12203
6. Balmer, N. V., Klima, S., Rempel, E. et al. (2014b). From transient transcriptome responses to disturbed neurodevelopment: Role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol 88, 1451-1468. http://dx.doi.org/10.1007/s00204-014-1279-6
7. Barbaric, I., Miller, G. and Dear, T. N. (2007). Appearances can be deceiving: Phenotypes of knockout mice. Briefings Functional Genomics Proteomics 6, 91-103. http://doi.org/10.1093/bfgp/elm008
8. Basketter, D. A., Clewell, H., Kimber, I. et al. (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 29, 3-89.
9. Blaauboer, B. J., Boekelheide, K., Clewell, H. J. et al. (2012). The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX 29, 411-425. http://doi.org/10.14573/altex.2012.4.411
10. Bottini, A. A. and Hartung, T. (2009). Food for thought ⋯ on economics of animal testing. ALTEX 26, 3-16. http://www.altex.ch/Current-issue.50.html?iid=104&aid=1
11. Bouhifd, M., Hartung, T., Hogberg, H. T. et al. (2013). Review: Toxicometabolomics. J Appl Toxicol 33, 1365-1383. http://dx.doi.org/10.1002/jat.2874.
12. Bouhifd, M., Andersen, M. E., Baghdikian, C. et al. (2015a). The Human Toxome project. ALTEX 32, 112-124. http://dx.doi.org/10.14573/altex.1502091
13. Bouhifd, M., Beger, R., Flynn, T. et al. (2015b). Quality Assurance of Metabolomics. ALTEX, in press.
14. Brink, C. B., Pretorius, A., van Niekerk, B. P. et al. (2008). Studies on cellular resilience and adaptation following acute and repetitive exposure to ozone in cultured human epithelial (HeLa) cells. Redox Rep 13, 87-100. http://dx.doi.org/10.1179/135100008X259187
15. Buchman, T. G. (2002). The community of the self. Nature 420, 246-251. http://doi.org/10.1038/nature01260
16. Burke, S. L., Hammell, M. and Ambros, V. (2015). Robust distal tip cell pathfinding in the face of temperature stress is ensured by two conserved microRNAS in Caenorhabditis elegans. Genetics 200, 1201-1218. http://doi.org/10.1534/genetics.115.179184
17. Calabrese, E. J. and Baldwin, L. A. (2001). The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 62, 330-338. http://dx.doi.org/10.1093/toxsci/62.2.330
18. Calabrese, E. and Blain, R. (2005). The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: An overview. Toxicol Appl Pharmacol 202, 289-301. http://doi.org/10.1016/j.taap.2004.06.023
19. Chan, Y. C., Banerjee, J., Choi, S. Y. and Sen, C. K. (2012). miR-210: The master hypoxamir. Microcirculation 19, 215-223. http://doi.org/10.1111/j.1549-8719.2011.00154.x
20. Choi, D. C., Chae, Y.-J., Kabaria, S. et al. (2014). MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. J Neurosci 34, 12725-12737. http://doi.org/10.1523/JNEUROSCI.0985-14.2014
21. Clapp, C., Portt, L., Khoury, C. et al. (2012). Untangling the roles of anti-apoptosis in regulating programmed cell death using humanized yeast cells. Front Oncol 2, 59. http://doi.org/10.3389/fonc.2012.00059.
22. Clemedson, C. and Ekwall, B. (1999). Overview of the final MEIC results: I. The in vitro/in vitro evaluation. Toxicol In Vitro 13, 657-663. http://dx.doi.org/10.1016/S0887-2333 (99)00060-0
23. Clemedson, C. (2008). The European ACuteTox project: A modern integrative in vitro approach to better prediction of acute toxicity. Clin Pharmacol Therapeut 84, 200-202. http://doi.org/10.1038/clpt.2008.135
24. Coecke, S., Ahr, H., Blaauboer, B. J. et al. (2006). Metabolism: A bottleneck in in vitro toxicological test development. Altern Lab Anim 34, 49-84.
25. Deshmukh, M. and Johnson, E. M. Jr. (1998). Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 21, 695-705. http://dx.doi.org/10.1016/S0896-6273(00)80587-5
26. Di Mauro, C., Bouchon, S., Logtmeijer, C. et al. (2010). Structured approach to identifying European critical infrastructures. Int J Critical Infrastructures 6, 277-292. http://dx.doi.org/10.1504/IJCIS.2010.033340
27. Dunn, J. F., Wu, Y., Zhao, Z. et al. (2012). Training the brain to survive stroke. PLoS One 7, e45108. http://dx.doi.org/10.1371/journal.pone.0045108
28. Ebert, M. S. and Sharp, P. A. (2012). Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524. http://doi.org/10.1016/j.cell.2012.04.005
29. Efremova, L., Schildknecht, S., Adam, M. et al. (2015). Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism. Br J Pharmacol 172, 4119-4132. http://dx.doi.org/10.1111/bph.13193
30. Ekwall, B. (1999). Overview of the final MEIC results: II. The in vitro-in vivo evaluation, including the selection of a practical battery of cell tests for prediction of acute lethal blood concentrations in humans. Toxicol In Vitro 13, 665-673. http://dx.doi.org/10.1016/S0887-2333(99)00061-2
31. Esteller, M. (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genetics 8, 286-298. http://doi.org/10.1038/nrg2005
32. Finch, C. E., Morgan, T. E., Longo, V. D. and de Magalhaes, J. P. (2010). Cell resilience in species life spans: A link to inflammation? Aging Cell 9, 519-526.
33. Foghsgaard, L., Wissing, D., Mauch, D. et al. (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153, 999-1010. http://dx.doi.org/10.1083/jcb.153.5.999
34. Fraga, M. F., Ballestar, E., Paz, M. F. et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci 102, 10604-10609. http://doi.org/10.1073/pnas.0500398102
35. Fragkouli, A. and Doxakis, E. (2014). miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway. Front Cellul Neurosci 8, 182-182. http://doi.org/10.3389/fncel.2014.00182
36. Hales, C. N. and Barker, D. J. (1992). Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35, 595-601. http://dx.doi.org/10.1007/BF00400248
37. Halle, W. and Goeres, E. (1988). Register der Zytotoxizität (IC50) in der Zellkultur und Möglichkeiten zur Abschätzung der akuten Toxizität (LD50). In P. Oehme, H. Loewe and E. Goeres (eds.), Beiträge zur Wirkstofforschung, 108 pp. Berlin, Germany: Institut für Wirkstofforschung.
38. Halle, W. (2003). The registry of cytotoxicity: Toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals. Altern Lab Anim 31, 89-198.
39. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
40. Hansson, O., Nylandsted, J., Castilho, R. F. et al. (2003). Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Res 970, 47-57. http://dx.doi.org/10.1016/S0006-8993(02)04275-0
41. Hartung, T. and Wendel, A. (1992). Endotoxin-inducible cytotoxicity in liver cell cultures - II: Demonstration of endotoxin-tolerance. Biochem Pharmacol 43, 191-196. http://dx.doi.org/10.1016/0006-2952(92)90277-P
42. Hartung, T. (2007). Food for thought ⋯ on cell culture. ALTEX 24, 143-147. http://www.altex.ch/All-issues/Issue.50.html?iid=87&aid=2
43. Hartung, T. and McBride, M. (2011). Food for thought ⋯ on mapping the human toxome. ALTEX 28, 83-93. http://dx.doi.org/10.14573/altex.2011.2.083
44. Hartung, T., van Vliet, E., Jaworska, J. et al. (2012). Systems toxicology. ALTEX 29, 119-128. http://dx.doi.org/10.14573/altex.2012.2.119
45. Hartung, T., Stephens, M. and Hoffmann, S. (2013). Mechanistic validation. ALTEX 30, 119-130. http://dx.doi.org/10.14573/altex.2013.2.119
46. He, Y., Michaels, S. D. and Amasino, R. M. (2003). Regulation of flowering time by histone acetylation in Arabidopsis. Science 302, 1751-1754. http://doi.org/10.1126/science.1091109
47. Heisch, C. (1860). The arsenic eaters of Styria. Boston Med Surg J 62, 484-488. http://dx.doi.org/10.1056/NEJM186007120622404
48. Hendriks, G., Atallah, M., Morolli, B. et al. (2012). The ToxTracker assay: Novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals. Toxicol Sci 125, 285-298. http://dx.doi.org/10.1093/toxsci/kfr281
49. Herranz, H. and Cohen, S. M. (2010). MicroRNAs and gene regulatory networks: Managing the impact of noise in biological systems. Genes Dev 24, 1339-1344. http://doi.org/10.1101/gad.1937010
50. Hirt, U. A., Gantner, F. and Leist, M. (2000). Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J Immunol 164, 6520-6529. http://dx.doi.org/10.4049/jimmunol.164.12.6520
51. Hirt, U. A. and Leist, M. (2003). Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 10, 1156-1164. http://dx.doi.org/10.1038/sj.cdd.4401286
52. Hoeng, J., Talikka, M., Martin, F. et al. (2014). Case study: The role of mechanistic network models in systems toxicology. Drug Discov Today 19, 183-192.
53. Hood, L. and Perlmutter, R. M. (2004). The impact of systems approaches on biological problems in drug discovery. Nat Biotechnol 22, 1215-1217. http://doi.org/10.1038/nbt1004-1215
54. Ivatt, R. and Whitworth, A. J. (2014). SREBF1 links lipogenesis to mitophagy and sporadic Parkinson's disease. Autophagy 10, 33-34. http://dx.doi.org/10.4161/auto.29642
55. Jack, J., Wambaugh, J. and Shah, I. (2013). Systems toxicology from genes to organs. Meth Molec Biol 930, 375-397. http://doi.org/10.1007/978-1-62703-059-5-17
56. Jaiswal, J. K., Lauritzen, S. P., Scheffer, L. et al. (2014). S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat Commun 5, 3795. http://dx.doi.org/10.1038/ncomms4795
57. Jennings, P. (2013). Stress response pathways, toxicity pathways and adverse outcome pathways. Arch Toxicol 87, 13-14. http://dx.doi.org/10.1007/s00204-012-0974-4
58. Jurk, D., Wang, C., Miwa, S. et al. (2012). Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996-1004. http://dx.doi.org/10.1111/j.1474-9726.2012.00870.x
59. Kim, D., Frank, C. L., Dobbin, M. M. et al. (2008). Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817. http://dx.doi.org/10.1016/j.neuron.2008.10.015
60. Kim, S. Y., He, Y., Jacob, Y. et al. (2005). Establishment of the vernalization-responsive, winter-annual habit in Arabidopsis requires a putative histone H3 methyl transferase. Plant Cell 17, 3301-3310. http://doi.org/10.1105/tpc.105.034645
61. Kinsner-Ovaskainen, A., Prieto, P., Stanzel, S. and Kopp-Schneider, A. (2013). Selection of test methods to be included in a testing strategy to predict acute oral toxicity: An approach based on statistical analysis of data collected in phase 1 of the ACuteTox project. Toxicol In Vitro 27, 1377-1394. http://dx.doi.org/10.1016/j.tiv.2012.11.010
62. Kleensang, A., Maertens, A., Rosenberg, M. et al. (2014). Pathways of Toxicity. ALTEX 31, 53-61. http://dx.doi.org/10.14573/altex.1309261
63. Koch, I. and Ackermann, J. (2012). On functional module detection in metabolic networks. Metabolites 3, 673-700. http://doi.org/10.3390/metabo3030673
64. Kreeger, P. K. and Lauffenburger, D. A. (2010). Cancer systems biology: A network modeling perspective. Carcinogenesis 31, 2-8. http://doi.org/10.1093/carcin/bgp261
65. Krug, A. K., Kolde, R., Gaspar, J. A. et al. (2013). Human embryonic stem cell-derived test systems for developmental neurotoxicity: A transcriptomics approach. Arch Toxicol 87, 123-143. http://dx.doi.org/10.1007/s00204-012-0967-3
66. Krug, A. K., Gutbier, S., Zhao, L. et al. (2014). Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+. Cell Death Dis 5, e1222. http://dx.doi.org/10.1038/cddis.2014.166
67. Lau, C. and Rogers, J. M. (2004). Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today 72, 300-312. http://dx.doi.org/10.1002/bdrc.20029
68. Lehner, M. D. and Hartung, T. (2002). Endotoxin tolerance - mechanisms and beneficial effects in bacterial infection. Rev Physiol Biochem Pharmacol 144, 95-141. http://dx.doi.org/10.1007/BFb0116586
69. Leist, M., Hasiwa, N., Rovida, C. et al. (2014). Consensus report on the future of animal-free systemic toxicity testing. ALTEX 31, 341-356. http://dx.doi.org/10.14573/altex.1406091
70. Leist, M. and Jäättelä, M. (2001). Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2, 589-598. http://dx.doi.org/10.1038/35085008
71. Leist, M. and Jäättelä, M. (2002). Burning up TNF toxicity for cancer therapy. Nat Med 8, 667-668. http://dx.doi.org/10.1038/nm0702-667
72. Limonciel, A., Moenks, K., Stanzel, S. et al. (2015). Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro, Epub ahead of print. http://doi.org/10.1016/j.tiv.2014.12.011
73. Lin, Z. and Will, Y. (2011). Evaluation of drugs with specific organ toxicities in organ specific cell lines. Toxicol Sci 126, 114-127. http://doi.org/10.1093/toxsci/kfr339
74. Lindblom, R., Ververis, K., Tortorella, S. M. and Karagiannis, T. C. (2015). The early life origin theory in the development of cardiovascular disease and type 2 diabetes. Mol Biol Rep 42, 791-797. http://dx.doi.org/10.1007/s11033-014-3766-5.
75. Linkov, I, Kröger, W., Levermann, A. et al. (2014). Changing the resilience paradigm. Nature Climate Change 4, 407-409. http://dx.doi.org/10.1038/nclimate2227
76. Loscalzo, J. (2010). The cellular response to hypoxia: Tuning the system with microRNAs. J Clin Invest 120, 3815-3817. http://dx.doi.org/10.1172/JCI45105
77. Macia, J. and Sole, R. V. (2009). Distributed robustness in cellular networks: Insights from synthetic evolved circuits. J R Soc Interface 6, 393-400. http://dx.doi.org/10.1098/rsif.2008.0236
78. Maertens, A., Luechtefeld, T., Kleensang, A. and Hartung, T. (2015). MPTP's pathway of toxicity indicates central role of transcription factor SP1. Arch Toxicol 89, 743-755. http://dx.doi.org/10.1007/s00204-015-1509-6.
79. Manke, T., Demetrius, L. and Vingron, M. (2006). An entropic characterization of protein interaction networks and cellular robustness. J R Soc Interface 3, 843-850. http://dx.doi.org/10.1098/rsif.2006.0140
80. Mattson, M. P. (2008). Hormesis defined. Ageing Res Rev 7, 1-7. http://dx.doi.org/10.1016/j.arr.2007.08.007
81. McGowan, P. O., Sasak, A., D'Alessio, A. C. et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12, 342-348. http://dx.doi.org/10.1038/nn.2270
82. Meda, F., Folci, M., Baccarelli, A. and Selmi, C. (2011). The epigenetics of autoimmunity. Cell Molec Immunol 8, 226-236. http://doi.org/10.1038/cmi.2010.78
83. Melton, D. W. (1994). Gene targeting in the mouse. Bioessays 16, 633-638. http://dx.doi.org/10.1002/bies.950160907
84. Miller, R. M., Callahan, L. M., Casaceli, C. et al. (2004). Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci 24, 7445-7454. http://doi.org/10.1523/JNEUROSCI.4204-03.2004
85. Mirbahai, L. and Chipman, J. K. (2014). Epigenetic memory of environmental organisms: A reflection of lifetime stressor exposures. Mutat Res Genet Toxicol Environ Mutagen 764-765, 10-17. http://doi.org/10.1016/j.mrgentox.2013.10.003
86. Miska, E. A., Alvarez-Saavedra, E., Abbott, A. L. et al. (2007). Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genetics 3, e215. http://doi.org/10.1371/journal.pgen.0030215
87. NIH - National Institutes of Health (2006). Background Review Document (BRD): Validation of neutral red uptake test methods for estimating acute oral systemic toxicity. Publication No. 07-4518, November 2006. http://iccvam.niehs.nih.gov/methods/acutetox/inv-nru-brd.htm
88. O'Neill, S., Ross, J. A., Wigmore, S. J. and Harrison, E. M. (2012). The role of heat shock protein 90 in modulating ischemia-reperfusion injury in the kidney. Expert Opin Investig Drugs 21, 1535-1548. http://dx.doi.org/10.1517/13543784.2012.713939
89. Ono, T., Ikehata, H., Vishnu Priya, P. and Uehara, Y. (2003). Molecular nature of mutations induced by irradiation with repeated low doses of X-rays in spleen, liver, brain and testis of lacZ-transgenic mice. Int J Radiat Biol 79, 635-641. http://dx.doi.org/10.1080/09553000310001596931
90. Potts, P. R., Singh, S., Knezek, M. et al. (2003). Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 163, 789-799. http://dx.doi.org/10.1083/jcb.200307130
91. Prieto, P., Cole, T., Curren, R. et al. (2013). Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50 > 2000 mg/kg): Results of an ECVAM validation study. Regulat Toxicol Pharmacol 65, 344-365. http://doi.org/10.1016/j.yrtph.2012.11.013
92. Qiu, Z., Norflus, F., Singh, B. et al. (2006). Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J Biol Chem 281, 16672-16680. http://dx.doi.org/10.1074/jbc.M511648200
93. Qureshi, I. A. and Mehler, M. F. (2011). Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep 11, 464-473. http://doi.org/10.1007/s11910-011-0210-2
94. Rahnenführer, J. and Leist, M. (2015). From smoking guns to footprints: Mining for critical events of toxicity pathways in transcriptome data. Arch Toxicol 89, 813-817. http://doi.org/10.1007/s00204-015-1497-6
95. Ramirez, T., Daneshian, M., Kamp, H. et al. (2013). Metabolomics in Toxicology and Preclinical Research. ALTEX 30, 209-225. http://dx.doi.org/10.14573/altex.2013.2.209
96. Reka, A. and Barabasi, A-L. (2002). Statistical mechanics of complex networks. Rev Modern Physics 74, 47. http://arXiv:cond-mat/0106096v1
97. Ren, Z. and Ambros, V. R. (2015). Caenorhabditis elegans microRNAs of the let-7 family act in innate immune response circuits and confer robust developmental timing against pathogen stress. Proc Natl Acad Sci 112, E2366-2375. http://doi.org/10.1073/pnas.1422858112
98. Roostalu, U. and Strähle, U. (2012). In vivo imaging of molecular interactions at damaged sarcolemma. Dev Cell 22, 515-529. http://dx.doi.org/10.1016/j.devcel.2011.12.008
99. Santpere, G., Nieto, M., Puig, B. and Ferrer, I. (2006). Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies. Neurosci Lett 397, 30-34. http://dx.doi.org/10.1016/j.neulet.2005.11.062
100. Sauer, J. M., Hartung, T., Leist, M. et al. (2015). Systems toxicology: The future of risk assessment. Int J Toxicol 34, 346-348. http://dx.doi.org/10.1177/1091581815576551
101. Scheffer, M., Carpenter, S. R., Lenton, T. M., et al. (2012). Anticipating critical transitions. Science 338, 344-348. http://doi.org/10.1126/science.1225244
102. Schrage, A., Hempel, K., Schulz, M. et al. (2011). Refinement and reduction of acute oral toxicity testing: A critical review of the use of cytotoxicity data. Altern Lab Animal 39, 273-295.
103. Sebert, S., Sharkey, D., Budge, H. and Symonds, M. E. (2011). The early programming of metabolic health: Is epigenetic setting the missing link? Am J Clin Nutr 94, Suppl 6, 1953S-1958S. http://dx.doi.org/10.3945/ajcn.110.001040
104. Seiler, A. E. and Spielmann, H. (2011). The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc 6, 961-978. http://doi.org/nprot.2011.348
105. Sipes, N. S., Martin, M. T., Kothiya, P. et al. (2013). Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol 26, 878-895. http://doi.org/10.1021/tx400021f
106. Smirnova, L., Sittka, A. and Luch, A. (2012). On the role of low-dose effects and epigenetics in toxicology. EXS 101, 499-550. http://doi.org/10.1007/978-3-7643-8340-4-18
107. Smirnova L., Harris G., Delp J. et al. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Arch Toxicol, revised.
108. Steinhardt, R. A. (2005). The mechanisms of cell membrane repair: A tutorial guide to key experiments. Ann New York Acad Sci 1066, 152-165. http://doi.org/10.1196/annals.1363.017
109. Stiegler, N. V., Krug, A. K, Matt. F. and Leist, M. (2011). Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 121, 73-87. http://dx.doi.org/10.1093/toxsci/kfr034.
110. Sturla, S. J., Boobis, A. R., FitzGerald, R. E. et al. (2014). Systems toxicology: From basic research to risk assessment. Chem Res Toxicol 27, 314-329. http://doi.org/10.1021/tx400410s
111. Suderman, M., McGowan, P. O., Sasaki, A. et al. (2012). Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus. Proc Natl Acad Sci U S A 109, Suppl 2, 17266-17272. http://dx.doi.org/10.1073/pnas.1121260109
112. Szyf, M. (2007). The dynamic epigenome and its implications in toxicology. Toxicol Sci 100, 7-23. http://doi.org/10.1093/toxsci/kfm177
113. Szyf, M. (2011). DNA methylation, the early-life social environment and behavioral disorders. J Neurodevelop Disorders 3, 238-249. http://doi.org/10.1007/s11689-011-9079-2
114. Tagore, S. and De, R. K. (2011). Detecting breakdown points in metabolic networks. Comput Biol Chem 35, 371-380. http://dx.doi.org/10.1016/j.compbiolchem.2011.10.007
115. Taleb, N. N. (2007). The black swan - the impact of the highly improbable. New York, USA: The Random House Publishing Group.
116. Taleb, N. N. (2012). Antifragile: Things that gain from disorder. New York, USA: The Random House Publishing Group.
117. Tang, H. L., Tang, H. M., Mak, K. H. et al. (2012). Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Molec Biol Cell 23, 2240-2252. http://doi.org/10.1091/mbc.E11-11-0926
118. Tang, H. L., Tang, H. M., Hardwick, J. M. and Fung, M. C. (2015). Strategies for tracking anastasis, a cell survival phenomenon that reverses apoptosis. J Visualized Exp 96, e51964. http://doi.org/10.3791/51964
119. Thomas, R. S., Black, M. B., Li, L. et al. (2012). A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol Sci 128, 398-417. http://doi.org/10.1093/toxsci/kfs159
120. Thomas, R. S., Philbert, M. A., Auerbach, S. S. et al. (2013). Incorporating new technologies into toxicity testing and risk assessment: Moving from 21st century vision to a data-driven framework. Toxicol Sci 136, 4-18. http://doi.org/10.1093/toxsci/kft178
121. Tyagi, E., Zhuang, Y., Agrawal, R. et al. (2015). Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet. Neurobiol Dis 73, 307-318. http://doi.org/10.1016/j.nbd.2014.09.014
122. Tyson, J. J., Chen, K. C. and Novak, B. (2003). Sniffers, buzzers, toggles and blinkers: Dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15, 221-231. http://doi.org/10.1016/S0955-0674(03)00017-6
123. Vandegehuchte, M. B. and Janssen, C. R. (2014). Epigenetics in an ecotoxicological context. Mutat Res Genet Toxicol Environ Mutagen 764-765, 36-45. http://doi.org/10.1016/j.mrgen-tox.2013.08.008
124. Velichko, A. K., Markova, E. N., Petrova, N. V. et al. (2013). Mechanisms of heat shock response in mammals. Cell Molec Life Sci 70, 4229-4241. http://doi.org/10.1007/s00018-013-1348-7
125. Vijg, J., Dollé, M. E., Martus, H. J. and Boerrigter, M. E. (1997). Transgenic mouse models for studying mutations in vivo: Applications in aging research. Mech Ageing Dev 99, 257-271. http://dx.doi.org/10.1016/s0047-6374(97)00107-3
126. Visan, A., Hayess, K., Sittner, D. et al. (2012). Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro. Neurotoxicol 33, 1135-1146. http://doi.org/10.1016/j.neuro.2012.06.006
127. Wallin, I. E. (1923). The mitochondria problem. Am Naturalist 57, 255-261. http://dx.doi.org/10.1086/279919
128. Wang, J. and Bannon, M. J. (2005). Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93, 474-482. http://dx.doi.org/10.1111/j.1471-4159.2005.03051.x
129. Wang, Y., Reis, C., Applegate, R. 2nd et al. (2015). Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke. Exp Neurol, Epub ahead of print.http://dx.doi.org/10.1016/j.expneurol.2015.04.009
130. Wetmore, B. A., Wambaugh, J. F., Ferguson, S. S. et al. (2013). Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays. Toxicol Sci 132, 327-346. http://doi.org/10.1093/toxsci/kft012
131. Wink, S., Hiemstra, S., Huppelschoten, S. et al. (2014). Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment. Chem Res Toxicol 27, 338-355. http://dx.doi.org/10.1021/tx4004038
132. Wu, K. H., Mo, X. M., Han, Z. C. and Zhou, B. (2012). Cardiac cell therapy: Pre-conditioning effects in cell-delivery strategies. Cytotherapy 14, 260-266. http://dx.doi.org/10.3109/14653249.2011.643780
133. Ye, Q., Zhang, X., Huang, B. et al. (2013). Astaxanthin suppresses MPP-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar Drugs 11, 1019-1034. http://dx.doi.org/10.3390/md11041019
134. Yehuda, R., Flory, J. D., Bierer, L. M. et al. (2015). Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry 77, 356-364. http://dx.doi.org/10.1016/j.biopsych.2014.02.006
135. Yellon, D. M. and Hausenloy, D. J. (2005). Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med 2, 568-575. http://dx.doi.org/10.1038/ncpcardio0346
136. Zhong, W. X., Wang, Y. B., Peng, L. et al. (2012). Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine beta-synthase: A target for neuronal antioxidant defense. J Biol Chem 287, 34189-34201. http://dx.doi.org/10.1074/jbc.M112.383646